YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Saved in:
| Title: | YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. |
|---|---|
| Authors: | Ye S; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Lawlor MA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rivera-Reyes A; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Egolf S; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Chor S; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Pak K; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Ciotti GE; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Lee AC; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Marino GE; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Shah J; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Niedzwicki D; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Weber K; Department of Orthopedic Surgery, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Park PMC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Alam MZ; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Grazioli A; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland., Haldar M; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Xu M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Perry JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. karineis@pennmedicine.upenn.edu Jun_qi@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Eisinger-Mathason TSK; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. karineis@pennmedicine.upenn.edu Jun_qi@dfci.harvard.edu. |
| Source: | Cancer research [Cancer Res] 2018 May 15; Vol. 78 (10), pp. 2705-2720. Date of Electronic Publication: 2018 Feb 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29490948 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ye+S%22">Ye S</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Lawlor+MA%22">Lawlor MA</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rivera-Reyes+A%22">Rivera-Reyes A</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Egolf+S%22">Egolf S</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Chor+S%22">Chor S</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Pak+K%22">Pak K</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Ciotti+GE%22">Ciotti GE</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Lee+AC%22">Lee AC</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Marino+GE%22">Marino GE</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Shah+J%22">Shah J</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Niedzwicki+D%22">Niedzwicki D</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Weber+K%22">Weber K</searchLink>; Department of Orthopedic Surgery, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Park+PMC%22">Park PMC</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Alam+MZ%22">Alam MZ</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Grazioli+A%22">Grazioli A</searchLink>; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Haldar+M%22">Haldar M</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Xu+M%22">Xu M</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Perry+JA%22">Perry JA</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Qi+J%22">Qi J</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. karineis@pennmedicine.upenn.edu Jun&#95;qi@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Eisinger-Mathason+TSK%22">Eisinger-Mathason TSK</searchLink>; Abramson Family Cancer Research Institute, Department of Pathology & Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. karineis@pennmedicine.upenn.edu Jun&#95;qi@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2018 May 15; Vol. 78 (10), pp. 2705-2720. <i>Date of Electronic Publication: </i>2018 Feb 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29490948 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-17-4052 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2705 Titles: – TitleFull: YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ye S – PersonEntity: Name: NameFull: Lawlor MA – PersonEntity: Name: NameFull: Rivera-Reyes A – PersonEntity: Name: NameFull: Egolf S – PersonEntity: Name: NameFull: Chor S – PersonEntity: Name: NameFull: Pak K – PersonEntity: Name: NameFull: Ciotti GE – PersonEntity: Name: NameFull: Lee AC – PersonEntity: Name: NameFull: Marino GE – PersonEntity: Name: NameFull: Shah J – PersonEntity: Name: NameFull: Niedzwicki D – PersonEntity: Name: NameFull: Weber K – PersonEntity: Name: NameFull: Park PMC – PersonEntity: Name: NameFull: Alam MZ – PersonEntity: Name: NameFull: Grazioli A – PersonEntity: Name: NameFull: Haldar M – PersonEntity: Name: NameFull: Xu M – PersonEntity: Name: NameFull: Perry JA – PersonEntity: Name: NameFull: Qi J – PersonEntity: Name: NameFull: Eisinger-Mathason TSK IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 05 Text: 2018 May 15 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 78 – Type: issue Value: 10 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |